Quantitative Phosphoproteomic Analysis in Alpha-Synuclein Transgenic Mice Reveals the Involvement of Aberrant p25/Cdk5 Signaling in Early-stage Parkinson’s Disease-Reference-Cited by-同舟云学术

Quantitative Phosphoproteomic Analysis in Alpha-Synuclein Transgenic Mice Reveals the Involvement of Aberrant p25/Cdk5 Signaling in Early-stage Parkinson’s Disease

Published:2020-02-03 Issue:6 Volume:40 Page:897-909
ISSN:0272-4340
Container-title:Cellular and Molecular Neurobiology
language:en
Short-container-title:Cell Mol Neurobiol

Author:

He Feng,Qi Guangjian,Zhang Qian,Cai Hongwei,Li Tongxia,Li Ming,Zhang Qiaofeng,Chen Jingyu,Ming Jie,Tian Bo,Zhang Pei^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Cellular and Molecular Neuroscience,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10571-019-00780-7.pdf

Reference42 articles.

1. Bulat V, Rast M, Pielage J (2014) Presynaptic CK2 promotes synapse organization and stability by targeting Ankyrin2. J Cell Biol 204(1):77–94. https://doi.org/10.1083/jcb.201305134

2. Chu Y, Morfini GA, Langhamer LB, He Y, Brady ST, Kordower JH (2012) Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease. Brain 135(Pt 7):2058–2073. https://doi.org/10.1093/brain/aws133

3. Cortes N, Guzman-Martinez L, Andrade V, Gonzalez A, Maccioni RB (2019) CDK5: A Unique CDK and Its Multiple Roles in the Nervous System. J Alzheimers Dis 68(3):843–855. https://doi.org/10.3233/JAD-180792

4. Cruz JC, Tseng HC, Goldman JA, Shih H, Tsai LH (2003) Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40(3):471–483

5. Dhavan R, Tsai LH (2001) A decade of CDK5. Nat Rev Mol Cell Biol 2(10):749–759. https://doi.org/10.1038/35096019

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated network pharmacology and phosphoproteomic analyses of Baichanting in Parkinson's disease model mice;Heliyon;2024-03

2. SNAP25 is a potential target for early stage Alzheimer’s disease and Parkinson’s disease;European Journal of Medical Research;2023-12-06

3. Proteostatic modulation in brain aging without associated Alzheimer’s disease-and age-related neuropathological changes;Aging;2023-05-13

4. Cdk5 and aberrant cell cycle activation at the core of neurodegeneration;Neural Regeneration Research;2023

5. Mass spectrometry–based approaches for the identification of molecular mechanism of action of ayurvedic medicines in Parkinson disease;Ayurvedic Herbal Preparations in Neurological Disorders;2023